Literature DB >> 20221892

Molecular markers for discriminating Streptococcus pyogenes and S. dysgalactiae subspecies equisimilis.

D J McMillan1, T Vu, P V Bramhachari, S Y Kaul, A Bouvet, M S Shaila, M G Karmarkar, K S Sriprakash.   

Abstract

Given the increasing aetiological importance of Streptococcus dysgalactiae subspecies equisimilis in diseases which are primarily attributed to S. pyogenes, molecular markers are essential to distinguish these species and delineate their epidemiology more precisely. Many clinical microbiology laboratories rely on agglutination reactivity and biochemical tests to distinguish them. These methods have limitations which are particularly exacerbated when isolates with mixed properties are encountered. In order to provide additional distinguishing parameters that could be used to unequivocally discriminate these two common pathogens, we assess here three molecular targets: the speB gene, intergenic region upstream of the scpG gene (IRSG) and virPCR. Of these, the former two respectively gave positive and negative results for S. pyogenes, and negative and positive results for S. dysgalactiae subsp. equisimilis. Thus, a concerted use of these nucleic acid-based methods is particularly helpful in epidemiological surveillance to accurately assess the relative contribution of these species to streptococcal infections and diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20221892     DOI: 10.1007/s10096-010-0899-x

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  39 in total

1.  Characterization of blood culture isolates of Streptococcus dysgalactiae subsp. equisimilis possessing Lancefield's group A antigen.

Authors:  C M Brandt; G Haase; N Schnitzler; R Zbinden; R Lütticken
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

Review 2.  Pyogenic streptococci of Lancefield groups C and G as pathogens in man.

Authors:  A Efstratiou
Journal:  Soc Appl Bacteriol Symp Ser       Date:  1997

3.  Genetic mosaic upstream of scpG in human group G streptococci contains sequences from group A streptococcal virulence regulon.

Authors:  K S Sriprakash; J Hartas
Journal:  Adv Exp Med Biol       Date:  1997       Impact factor: 2.622

Review 4.  The global burden of group A streptococcal diseases.

Authors:  Jonathan R Carapetis; Andrew C Steer; E Kim Mulholland; Martin Weber
Journal:  Lancet Infect Dis       Date:  2005-11       Impact factor: 25.071

5.  Presumptive identification of streptococci by pyrrolidonyl-beta-naphthylamide (PYR) test.

Authors:  C H Chen; L U Huang; J H Lee; W H Lee
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  1997-04

6.  Virulence profiling of Streptococcus dysgalactiae subspecies equisimilis isolated from infected humans reveals 2 distinct genetic lineages that do not segregate with their phenotypes or propensity to cause diseases.

Authors:  Mark R Davies; David J McMillan; Robert G Beiko; Vanessa Barroso; Robert Geffers; Kadaba S Sriprakash; Gursharan S Chhatwal
Journal:  Clin Infect Dis       Date:  2007-04-19       Impact factor: 9.079

7.  Disease burden due to Streptococcus dysgalactiae subsp. equisimilis (group G and C streptococcus) is higher than that due to Streptococcus pyogenes among Mumbai school children.

Authors:  Pallaval V Bramhachari; Santosh Y Kaul; David J McMillan; Melkote S Shaila; Mohan G Karmarkar; Kadaba S Sriprakash
Journal:  J Med Microbiol       Date:  2009-10-15       Impact factor: 2.472

8.  Rapid identification of group A streptococci by the Strep-A-Fluor system.

Authors:  T C Wu; E C Williams; P S Conville
Journal:  Diagn Microbiol Infect Dis       Date:  1987-01       Impact factor: 2.803

9.  Presumptive identification of streptococci with a new test system.

Authors:  R R Facklam; L G Thacker; B Fox; L Eriquez
Journal:  J Clin Microbiol       Date:  1982-06       Impact factor: 5.948

Review 10.  What happened to the streptococci: overview of taxonomic and nomenclature changes.

Authors:  Richard Facklam
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

View more
  9 in total

1.  The classical lancefield antigen of group a Streptococcus is a virulence determinant with implications for vaccine design.

Authors:  Nina M van Sorge; Jason N Cole; Kirsten Kuipers; Anna Henningham; Ramy K Aziz; Ana Kasirer-Friede; Leo Lin; Evelien T M Berends; Mark R Davies; Gordon Dougan; Fan Zhang; Samira Dahesh; Laura Shaw; Jennifer Gin; Madeleine Cunningham; Joseph A Merriman; Julia Hütter; Bernd Lepenies; Suzan H M Rooijakkers; Richard Malley; Mark J Walker; Sanford J Shattil; Patrick M Schlievert; Biswa Choudhury; Victor Nizet
Journal:  Cell Host Microbe       Date:  2014-06-11       Impact factor: 21.023

2.  Detection of group a streptococcal pharyngitis by quantitative PCR.

Authors:  Eileen M Dunne; Julia L Marshall; Ciara A Baker; Jayne Manning; Gena Gonis; Margaret H Danchin; Pierre R Smeesters; Catherine Satzke; Andrew C Steer
Journal:  BMC Infect Dis       Date:  2013-07-11       Impact factor: 3.090

3.  Complete genome sequencing and analysis of a Lancefield group G Streptococcus dysgalactiae subsp. equisimilis strain causing streptococcal toxic shock syndrome (STSS).

Authors:  Yumi Shimomura; Kayo Okumura; Somay Yamagata Murayama; Junji Yagi; Kimiko Ubukata; Teruo Kirikae; Tohru Miyoshi-Akiyama
Journal:  BMC Genomics       Date:  2011-01-11       Impact factor: 3.969

4.  Recombination drives genetic diversification of Streptococcus dysgalactiae subspecies equisimilis in a region of streptococcal endemicity.

Authors:  David J McMillan; Santosh Y Kaul; P V Bramhachari; Pierre R Smeesters; Therese Vu; M G Karmarkar; Melkote S Shaila; Kadaba S Sriprakash
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240

5.  Potential for Molecular Testing for Group A Streptococcus to Improve Diagnosis and Management in a High-Risk Population: A Prospective Study.

Authors:  Anna P Ralph; Deborah C Holt; Sharifun Islam; Joshua Osowicki; David E Carroll; Steven Y C Tong; Asha C Bowen
Journal:  Open Forum Infect Dis       Date:  2019-02-26       Impact factor: 3.835

Review 6.  Antibiotics and Carbohydrate-Containing Drugs Targeting Bacterial Cell Envelopes: An Overview.

Authors:  Federico Riu; Alessandro Ruda; Roberta Ibba; Simona Sestito; Ilenia Lupinu; Sandra Piras; Göran Widmalm; Antonio Carta
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-29

7.  Molecular basis for recognition of the Group A Carbohydrate backbone by the PlyC streptococcal bacteriophage endolysin.

Authors:  Harley King; Sowmya Ajay Castro; Amol Arunrao Pohane; Cynthia M Scholte; Vincent A Fischetti; Natalia Korotkova; Daniel C Nelson; Helge C Dorfmueller
Journal:  Biochem J       Date:  2021-06-25       Impact factor: 3.766

Review 8.  Bacterial glycobiology: rhamnose-containing cell wall polysaccharides in Gram-positive bacteria.

Authors:  Michel-Yves Mistou; Iain C Sutcliffe; Nina M van Sorge
Journal:  FEMS Microbiol Rev       Date:  2016-03-13       Impact factor: 16.408

9.  Molecular Epidemiology of Noninvasive and Invasive Group A Streptococcal Infections in Cape Town.

Authors:  D D Barth; P Naicker; K Engel; B Muhamed; W Basera; B M Mayosi; J B Dale; M E Engel
Journal:  mSphere       Date:  2019-10-30       Impact factor: 4.389

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.